Akoya Biosciences, Inc.
We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through our CODEX and Phenoptics platforms, reagents, software and services, we offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum, from discovery through translational and clinical research.
|Industry:||Laboratory Analytical Instruments|
|Address||100 Campus Drive, 6th Floor Marlborough, MA 01752|
|Phone Number||(855) 896-8401|
|View Prospectus:||Akoya Biosciences, Inc.|
|Revenues||$42.44 mil (last 12 months)|
|Net Income||$-16.71 mil (last 12 months)|
|Price range||$20.00 - $20.00|
|Est. $ Volume||$131.6 mil|
|Manager / Joint Managers||J.P. Morgan/ Morgan Stanley/ Piper Sandler/ Canaccord Genuity|
|Expected To Trade:||4/16/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|